T1	CHEM 14 22	tiazidas
#1	AnnotatorNotes T1	C0012802; Thiazide Diuretics; Organic Chemical · Pharmacologic Substance
T2	PROC 29 39	profilaxis
#2	AnnotatorNotes T2	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T3	DISO 46 62	litiasis cálcica
T4	CHEM 55 62	cálcica
#3	AnnotatorNotes T4	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T5	CHEM 126 134	tiazidas
#4	AnnotatorNotes T5	C0012802; Thiazide Diuretics; Organic Chemical · Pharmacologic Substance
T6	PROC 141 151	profilaxis
#5	AnnotatorNotes T6	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T7	PROC 154 165	tratamiento
#6	AnnotatorNotes T7	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T8	DISO 200 216	litiasis cálcica
T9	CHEM 209 216	cálcica
#7	AnnotatorNotes T9	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T10	CHEM 220 227	oxalato
#8	AnnotatorNotes T10	C0029988; Oxalates; Organic Chemical
T11	CHEM 230 245	fosfato cálcico
#9	AnnotatorNotes T11	C0006711; calcium phosphate; Pharmacologic Substance · Inorganic Chemical
T12	PROC 271 303	estudio prospectivo aleatorizado
#10	AnnotatorNotes T12	C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T13	PROC 312 323	seguimiento
#11	AnnotatorNotes T13	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T14	PROC 795 803	tratados
#12	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	PROC 355 369	diagnosticados
#13	AnnotatorNotes T15	C0011900; Diagnosis; Diagnostic Procedure
T16	CHEM 382 389	cálcica
#14	AnnotatorNotes T16	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T17	PROC 472 483	observación
#15	AnnotatorNotes T17	C0700325; Patient observation; Health Care Activity
T18	PROC 488 499	tratamiento
#16	AnnotatorNotes T18	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T19	CHEM 539 556	hidroclorotiazida
#17	AnnotatorNotes T19	C0020261; hydrochlorothiazide; Organic Chemical · Pharmacologic Substance
T20	CHEM 593 610	hidroclorotiazida
#18	AnnotatorNotes T20	C0020261; hydrochlorothiazide; Organic Chemical · Pharmacologic Substance
T21	CHEM 624 640	citrato potásico
#19	AnnotatorNotes T21	C0137996; potassium citrate; Organic Chemical · Pharmacologic Substance
T22	PROC 671 684	estudio renal
#20	AnnotatorNotes T22	C0846101; Renal study; Diagnostic Procedure
T23	PROC 689 707	técnicas de imagen
#21	AnnotatorNotes T23	C0079595; Imaging Techniques; Diagnostic Procedure
T24	PROC 711 738	estudio metabólico urinario
T25	CHEM 808 816	tiazidas
#22	AnnotatorNotes T25	C0012802; Thiazide Diuretics; Organic Chemical · Pharmacologic Substance
T26	PROC 1196 1204	tratados
#23	AnnotatorNotes T26	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T27	DISO 873 891	recidiva litiásica
#24	AnnotatorNotes T27	C0023869; Lithiasis; Pathologic Function + C2825055; Recurrence (disease attribute); Pathologic Function (?)
T28	PROC 513 521	tratados
#25	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	DISO 939 949	alteración
#26	AnnotatorNotes T29	C0221423; Illness (finding); Sign or Symptom
T30	PROC 981 999	estudio metabólico
T31	DISO 1004 1018	hipercalciuria
#27	AnnotatorNotes T31	C0020438; Hypercalciuria; Finding
T32	PROC 1135 1159	litotricia extracorpórea
#28	AnnotatorNotes T32	C0015359; Extracorporeal Shockwave Lithotripsy; Therapeutic or Preventive Procedure
T33	DISO 1181 1195	hipercalciuria
#29	AnnotatorNotes T33	C0020438; Hypercalciuria; Finding
T34	CHEM 1209 1217	tiazidas
#30	AnnotatorNotes T34	C0012802; Thiazide Diuretics; Organic Chemical · Pharmacologic Substance
T35	DISO 1358 1376	recidiva litiásica
#31	AnnotatorNotes T35	C0023869; Lithiasis; Pathologic Function + C2825055; Recurrence (disease attribute); Pathologic Function (?)
T36	CHEM 1382 1390	tiazidas
#32	AnnotatorNotes T36	C0012802; Thiazide Diuretics; Organic Chemical · Pharmacologic Substance
T37	DISO 1472 1488	litiasis cálcica
T38	CHEM 1481 1488	cálcica
#33	AnnotatorNotes T38	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T39	DISO 1549 1563	hipercalciuria
#34	AnnotatorNotes T39	C0020438; Hypercalciuria; Finding
T40	PROC 86 107	Demostrar la eficacia
#35	AnnotatorNotes T40	C1707887; Efficacy Study; Research Activity
T41	PROC 571 579	tratados
#36	AnnotatorNotes T41	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T42	ANAT 679 684	renal
#37	AnnotatorNotes T42	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T43	ANAT 730 738	urinario
#38	AnnotatorNotes T43	C0042036; Urine; Body Substance
T44	DISO 373 389	litiasis cálcica
T45	LIVB 186 195	pacientes
#39	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	Duration 327 336	tres años
T47	LIVB 345 354	pacientes
#40	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	LIVB 407 416	pacientes
#41	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	Neg_cue 484 487	sin
T50	Dose 526 531	50 mg
T51	Frequency 531 535	/día
T52	Dose 584 589	50 mg
T53	Frequency 640 644	/día
T54	Duration 746 763	12, 24 y 36 meses
T55	LIVB 785 794	pacientes
#42	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	LIVB 911 924	grupo control
#43	AnnotatorNotes T56	C0009932; Control Groups; Group
T57	LIVB 1167 1176	pacientes
#44	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	LIVB 1458 1467	pacientes
#45	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 1535 1544	pacientes
#46	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T62	Dose 613 620	20 mlEq
T60	DISO 173 182	recidivas
#47	AnnotatorNotes T60	C2825055; Recurrence (disease attribute); Pathologic Function
T61	DISO 1091 1100	recidivas
#48	AnnotatorNotes T61	C2825055; Recurrence (disease attribute); Pathologic Function
T63	DISO 1445 1454	recidivas
#49	AnnotatorNotes T63	C2825055; Recurrence (disease attribute); Pathologic Function
A1	Assertion T18 Negated
R1	Used_for Arg1:T1 Arg2:T2	
R2	Before Arg1:T2 Arg2:T3	
T64	Observation 63 74	recidivante
#50	AnnotatorNotes T64	C0679254; Disease recurrence; Finding
R3	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T64	
R4	Causes Arg1:T4 Arg2:T3	
R5	Used_for Arg1:T5 Arg2:T6	
R6	Used_for Arg1:T5 Arg2:T7	
R7	Before Arg1:T6 Arg2:T60	
R8	Before Arg1:T6 Arg2:T7	
R9	Experiences Arg1:T45 Arg2:T5	
R10	Experiences Arg1:T45 Arg2:T6	
R11	Experiences Arg1:T45 Arg2:T7	
R12	Experiences Arg1:T45 Arg2:T60	
R13	Causes Arg1:T9 Arg2:T8	
R14	Causes Arg1:T10 Arg2:T8	
R15	Causes Arg1:T11 Arg2:T8	
R16	Experiences Arg1:T45 Arg2:T8	
R17	Before Arg1:T8 Arg2:T60	
R18	Has_Duration_or_Interval Arg1:T13 Arg2:T46	
R21	Experiences Arg1:T47 Arg2:T44	
R22	Causes Arg1:T16 Arg2:T44	
T65	Observation 390 401	recidivante
#51	AnnotatorNotes T65	C0679254; Disease recurrence; Finding
R23	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T65	
R24	Before Arg1:T15 Arg2:T13	
R19	Experiences Arg1:T48 Arg2:T28	
R25	Negation Arg1:T49 Arg2:T18	
R26	Combined_with Arg1:T17 Arg2:T18	
R27	Used_for Arg1:T19 Arg2:T28	
R28	Has_Dose_or_Strength Arg1:T19 Arg2:T50	
R29	Has_Frequency Arg1:T19 Arg2:T51	
R30	Experiences Arg1:T48 Arg2:T41	
R31	Has_Dose_or_Strength Arg1:T20 Arg2:T52	
R32	Used_for Arg1:T20 Arg2:T41	
R33	Combined_with Arg1:T20 Arg2:T21	
R34	Has_Frequency Arg1:T20 Arg2:T53	
R35	Has_Dose_or_Strength Arg1:T21 Arg2:T62	
R36	Location_of Arg1:T42 Arg2:T22	
R38	Combined_with Arg1:T23 Arg2:T24	
R39	Location_of Arg1:T43 Arg2:T24	
R40	Overlap Arg1:T24 Arg2:T54	
R41	Overlap Arg1:T23 Arg2:T54	
T66	Quantifier_or_Qualifier 739 744	basal
#52	AnnotatorNotes T66	C1442488; Baseline; Quantitative Concept
R42	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T66	
R43	Overlap Arg1:T22 Arg2:T54	
R44	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T66	
R45	Experiences Arg1:T55 Arg2:T14	
R46	Used_for Arg1:T25 Arg2:T14	
R47	Experiences Arg1:T55 Arg2:T27	
R48	Experiences Arg1:T56 Arg2:T27	
#53	AnnotatorNotes T30	C0549074; Assessment: Metabolism; Health Care Activity (?)
R51	Before Arg1:T61 Arg2:T32	
R52	Experiences Arg1:T57 Arg2:T61	
R53	Experiences Arg1:T57 Arg2:T32	
R54	Experiences Arg1:T57 Arg2:T33	
R55	Experiences Arg1:T57 Arg2:T26	
R56	Used_for Arg1:T34 Arg2:T26	
R57	Overlap Arg1:T61 Arg2:T33	
T67	Observation 1055 1070	patrón litógeno
T68	Quantifier_or_Qualifier 1071 1076	mixto
#54	AnnotatorNotes T68	C0205430; Mixed (qualifier value); Functional Concept
R58	Has_Quantifier_or_Qualifier Arg1:T67 Arg2:T68	
T69	Observation 1340 1355	patrón litógeno
R59	Overlap Arg1:T69 Arg2:T35	
R60	Overlap Arg1:T29 Arg2:T67	
T70	Observation 1418 1438	factores litogénicos
R63	Experiences Arg1:T58 Arg2:T36	
R64	Experiences Arg1:T58 Arg2:T70	
R65	Experiences Arg1:T58 Arg2:T63	
R66	Experiences Arg1:T58 Arg2:T37	
R67	Causes Arg1:T38 Arg2:T37	
R68	Experiences Arg1:T59 Arg2:T39	
R69	Overlap Arg1:T70 Arg2:T63	
R70	Before Arg1:T37 Arg2:T63	
A2	Experiencer T45 Patient
A3	Experiencer T47 Patient
A4	Experiencer T48 Patient
A5	Experiencer T55 Patient
A6	Experiencer T56 Patient
A7	Experiencer T57 Patient
A8	Experiencer T58 Patient
A9	Experiencer T59 Patient
